University of Toyama   Report issue

Academic/Hospital Phase 2 Phase 3
Founded: Toyama Japan (1875)

Organization Overview

First Clinical Trial
2007
NCT00766480
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Department of Obstetrics and Gynecology,University of Toyama | University of Toyama

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Abortion, Habitual (Phase 3)

Abortion, Spontaneous (Phase 3)

Depression (Phase 3)

Lung Neoplasms (Phase 2)

Small Cell Lung Carcinoma (Phase 2)

Stress Disorders, Post-Traumatic (Phase 3)

Stress Disorders, Traumatic (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 8
  • # of Trial APIs: 8